Results 51 to 60 of about 7,668 (229)

Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society

Asia - Pacific Journal of Ophthalmology, 2021
Supplemental Digital Content is available in the text Purpose: Review and provide consensus recommendations on use of treat-and-extend (T&E) regimens for neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV ...
V. Chaikitmongkol, Sa-Hee Min, T. Lai, G. Tan, N. Ngah, M. Ohji, P. Mitchell, Chang-Hao Yang, Paisan Ruamviboonsuk, I. Wong, T. Sakamoto, A. Rajendran, You-xin Chen, D. Lam, Chi-Chun Lai, T. Wong, C. Cheung, A. Chang, A. Koh   +18 more
semanticscholar   +1 more source

Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study

Indian Journal of Ophthalmology, 2022
Purpose: To report the initial experience of managing treatment-resistant and treatment-naïve eyes with polypoidal choroidal vasculopathy (PCV) by using brolucizumab 6 mg. Methods: This was a retrospective multicentric series of all consecutive eyes with
D. Chakraborty, A. Maiti, S. Sengupta, S. Mondal, K. Nandi, S. Chakraborty   +5 more
semanticscholar   +1 more source

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

JAMA ophthalmology, 2020
This randomized clinical trial (EVEREST II) compares intravitreal ranibizumab with or without verteporfin photodynamic therapy among Asian patients with polypoidal choroidal vasculopathy at 24 months.
T. Lim, T. Lai, Kanji Takahashi, T. Wong, Lee‐Jen Chen, Paisan Ruamviboonsuk, Colin S. Tan, W. Lee, C. Cheung, N. Ngah, Ramune Patalauskaite, P. Margaron, A. Koh   +12 more
semanticscholar   +1 more source

Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence

Ophthalmology and Therapy, 2022
To analyze the efficacy and safety profile of the intravitreal ranibizumab biosimilar molecule, Razumab® (Intas Pharmaceuticals, Ahmedabad, India; BRm; Razumab®) and the innovator ranibizumab drug (IRm; LUCENTIS®) in Indian patients with polypoidal ...
Manoj Soman, Indu J. Nair, J. Sheth, Unnikrishnan Nair   +3 more
semanticscholar   +1 more source

Chorioretinal abnormalities in idiopathic intracranial hypertension: case reports

International Journal of Retina and Vitreous, 2022
Background Papilledema is the main ocular finding in patients with idiopathic intracranial hypertension (IIH) although several chorioretinal abnormalities may also occur and contribute to visual loss. The purpose of this paper is to describe two cases of
Leonardo E. Ariello, Luiz Guilherme Marchesi Mello, Sérgio Luis Gianotti Pimentel, Mário L. R. Monteiro   +3 more
doaj   +1 more source

OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT

, 2022
Purpose: To evaluate whether optical coherence tomography (OCT) can determine polypoidal lesion (PL) perfusion in polypoidal choroidal vasculopathy eyes after 12 months of aflibercept monotherapy.
Cheung, Gemmy Chui Ming, Ranjana Mathur, Chakravarthy, Usha, ChoI Mun Chan, Teo, Kelvin Yi Chong, Janice Marie Jordan-Yu, Gan, Alfred Tau Liang, Mathur, Ranjana, Vyas, Chinmayi Himanshuroy, Chinmayi Himanshuroy Vyas, Gemmy Chui Ming Cheung, Chan, ChoI Mun, Jordan-Yu, Janice Marie, Kelvin Yi Chong Teo, Anna C. S. Tan, Tan, Anna C. S., Alfred Tau Liang Gan, Tien Yin Wong, Usha Chakravarthy, Wong, Tien Yin   +19 more
core   +1 more source

A rare case of macular telangiectasia type 2 associated with polypoidal choroidal vasculopathy

Indian Journal of Ophthalmology. Case Reports, 2023
Polypoidal choroidal vasculopathy (PCV) was first described as subretinal polypoidal vascular lesions associated with serous and hemorrhagic pigment epithelial detachments.
Sampurna Bhattacharyya, Shamayita Gupta, Ahana Sen, Bristi Majumdar, Raghulnadhan Ramanadhane, Surabhi Chattree, Kumar Saurabh, Rupak Roy   +7 more
doaj   +1 more source

Consensus and Guidelines on Diagnosis and Management of Polypoidal Choroidal Vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS).

Asia - Pacific Journal of Ophthalmology
A panel of 21 international experts are formed by the Asia-Pacific Vitreo-retina Society to work out the consensus and guidelines on polypoidal choroidal vasculopathy (PCV).
Paisan Ruamviboonsuk, D. S. Ng, V. Chaikitmongkol, Andrew Chang, Shih-Jen Chen, Youxin Chen, Chui Ming Gemmy Cheung, F. Gomi, Robyn Guymer, Judy E. Kim, A. Koh, G. Kokame, Chi-Chun Lai, T. Lai, Won Ki Lee, Yuichiro Ogura, Srinivas R. Sadda, K. Teo, T. Wong, Yasuo Yanagi, Dennis S. C. Lam   +20 more
semanticscholar   +1 more source

Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population

Frontiers in Ophthalmology
Purpose To describe the early experiences of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) whose treatment was switched to faricimab from other anti-vascular endothelial growth factor (VEGF)
F. Ibrahim, K. Teo, Tien-En Tan, Hiok Hong Chan, P. Chandrasekaran, S. Lee, A. C. S. Tan, R. Mathur, C. M. Chan, S. Sim, Gavin Tan, I. Yeo, C M G Cheung   +12 more
semanticscholar   +1 more source

Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept

Scientific Reports
Intravitreal injection of aflibercept (IVA) has successfully treated polypoidal choroidal vasculopathy (PCV), and polyp morphology is an important indicator of treatment efficacy.
K. Sayanagi, Satoko Fujimoto, Chikako Hara, Yoko Fukushima, Kazuichi Maruyama, Ryo Kawasaki, Shigeru Sato, Kohji Nishida   +7 more
semanticscholar   +1 more source